Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04919317 · ClinicalTrials.gov registry record · Phase 2

Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty

A Phase 2 study of Pain, Postoperative and Mammaplasty, sponsored by Temple University.

Completed
Registry status
Phase 2
Development phase
56
Enrollment target
1
Study location

NCT04919317: Completed Phase 2 study of Pain, Postoperative and Mammaplasty, sponsored by Temple University.

NCT04919317 is a Phase 2 study of Pain, Postoperative and Mammaplasty that has completed, run by Temple University. The registered enrollment target is 56 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04919317, a Phase 2 study of Pain, Postoperative and Mammaplasty, has completed, sponsored by Temple University.

COMPLETED
Registry status
Phase 2
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The addition of dexamethasone to non-liposomal bupivacaine in perineural blocks has been shown to enhance pain control and prolong the time until first request for postoperative narcotics in the fields of orthopedic, thoracic, and gynecologic surgery. This has not been investigated in any types of breast surgery. The investigators assessed if the combination of dexamethasone to bupivacaine in the preoperative field block prior to bilateral breast reduction surgery resulted in improved pain control relative to bupivacaine alone.

Primary Outcome

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

Interventions

  • DRUG Saline
  • DRUG Dexamethasone 4mg

Study Locations (1)

Pennsylvania

  • Temple University Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2017-09-29
Est. Completion 2020-11-25
Phase Phase 2
Temple University

163 total trials

What the finished NCT04919317 record still lists

NCT04919317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (79% lower).

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT04919317 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04919317 about?

NCT04919317 is a clinical study titled "Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty". The addition of dexamethasone to non-liposomal bupivacaine in perineural blocks has been shown to enhance pain control and prolong the time until first request for postoperative narcotics in the fields of orthopedic, thoracic, and gynecologic surgery. This has not been investigated in any types of b...

What is the current status of trial NCT04919317?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2017-09-29. Estimated completion is 2020-11-25.

What conditions does trial NCT04919317 study?

This clinical trial studies the following conditions: Pain, Postoperative, Mammaplasty.

What interventions are being tested in trial NCT04919317?

The interventions under investigation include: Saline (DRUG), Dexamethasone 4mg (DRUG).

Who is sponsoring clinical trial NCT04919317?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04919317 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04919317's enrollment target sits among peer trials

56 86th of 113 higher than 27 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04919317, the US trial registry maintained by the National Library of Medicine. NCT04919317 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.